AI-Generated Summary

India's pharmaceutical sector is under renewed scrutiny regarding drug quality and compliance, following incidents of contaminated cough syrup linked to child deaths. The Union Health Ministry has mandated strict adherence to revised Schedule M norms, while regulatory bodies are taking action against non-compliant manufacturers. This underscores an urgent need for robust quality control and proactive monitoring to uphold the industry's integrity.

In a nutshell

This article highlights the global implications of pharmaceutical manufacturing standards, particularly from a major supplier like India, impacting supply chain reliability and patient safety worldwide. It underscores the critical role of stringent regulatory oversight in maintaining trust and ensuring the quality of essential medicines.

Source: The Hindu